Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFidelity Japan Trust Regulatory News (FJV)

  • This share is currently suspended. It was suspended at a price of 235.00
  • There is currently no data for FJV

Company Update

17 Apr 2025 07:00

Fidelity Japan Trust Plc - Company Update

Fidelity Japan Trust Plc - Company Update

PR Newswire

LONDON, United Kingdom, April 17

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.

 

17 April 2025

 

FIDELITY JAPAN TRUST PLC (the "Company" or "FJV")

 

Following the publication of the Company's 2024 final results on 27 March 2025, in which changes to the portfolio management team at Fidelity were also announced, and following the Company's announcement on 4 April 2025 in relation to the announcement made by AVI Japan Opportunity Trust Plc, the Board of FJV (the "Board") has held further discussions with representatives of a number of the Company's largest shareholders.

 

As required by the Company's Articles of Association, the Company's AGM notice dated 26 March 2025 includes a resolution for the Company to continue as an investment company (the "Continuation Resolution"). The result of the discussions referred to above is that the Board does not expect the Continuation Resolution to be approved by a majority of shareholders at the AGM on 21 May 2025.  In addition, the Board has subsequently received a small number of unsolicited and credible indicative proposals from outside parties.

 

The possibility that the Continuation Resolution might not be approved by a majority of shareholders was referenced in the 2024 Annual Report dated 26 March 2025. However, in accordance with the Articles of Association of the Company, the Continuation Resolution must still be put to the AGM on 21 May 2025. The Board continues to recommend shareholders vote in favour of all the resolutions being put at the Company's AGM on 21 May 2025, including the Continuation Resolution and the resolution which proposes to extend the time permitted to draw up proposals regarding the Company's voluntary liquidation and/or reorganisation in the event of an unsuccessful continuation vote.  At present the Board has three months from the date of the vote to draw up proposals and to convene and hold a general meeting. It is proposed to increase this to six months. The proposed new timeframe is felt to provide a more realistic time period to facilitate due diligence, for proposals to be fully considered, and is in line with market practice.

 

Notwithstanding the fact that the Board continues to recommend that shareholders approve the Continuation Resolution, the Board has decided it is in the interests of all shareholders to start immediately a formal review process to consider the future of the Company (the "Review").  

 

The Board believes it is important to consider the interests of all shareholders and has appointed Stifel Nicolaus Europe Limited ("Stifel") to prepare a process which will invite formal proposals to be made privately to the Board.  The focus of the Board will be on those parties who are able to demonstrate a current record of managing Japanese equities in an existing London listed investment company structure. This process will include an invitation to AVI Japan Opportunity Trust Plc.

 

If the Continuation Resolution is not approved by a majority of shareholders at the AGM, the Board is currently assuming that, as a result of the Review, the Company is likely to enter into a scheme of reconstruction pursuant to section 110 of the Insolvency Act 1986 (a "s.110 Scheme") later in 2025.  Any s.110 Scheme which is recommended by the Board to shareholders will require 75 per cent shareholder approval of those voting. As part of the Review, the Board will not actively consider the option of a transaction that would be subject to the Takeover Code, and do not believe such a transaction is a possible outcome of that Review.

 

The Board has been active on share buybacks during the last year.  However in light of the Review, it has decided to suspend on-market share buybacks by the Company.

 

The Company will update the market on the progress of the Review in due course, noting that at this stage there can be no certainty that the Review will result in a s.110 Scheme.

 

Enquiries

Fidelity Japan Trust Plc

David Graham (Chairman)

 

Via Stifel

Stifel

Edward Gibson-Watt

Andrew Yeo

 

Tel: +44 (0) 20 7710 7600

 

Important Information

 

This announcement is released by the Company and the information contained within this announcement is deemed by the Company to constitute inside information for the purposes of Article 7 of the UK version of the EU Market Abuse Regulation (Regulation (EU) No.596/2014) which forms part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended. Upon the publication of this announcement via a Regulatory Information Service, such information is now considered to be in the public domain.  The person responsible for arranging for the release of this announcement on behalf of the Company is David Graham, Chairman.

 

Legal Entity Identifier (LEI): 549300ND695NEJ5GPI72

 

Stifel Nicolaus Europe Limited ("Stifel"), which is authorised and regulated by the Financial Conduct Authority in the United Kingdom, is acting exclusively as financial advisor and broker to FJV and no one else in connection with the Review and the matters and arrangements set out in this announcement. Stifel will not regard any other person as its client in relation to the Review or any other matter or arrangement set out in this announcement and will not be responsible to anyone other than FJV for providing the protections afforded to clients of Stifel, nor for providing advice in relation to the Review or any other matter or arrangement referred to in this announcement. Neither Stifel nor any of its affiliates (nor their respective directors, officers, employees or agents) owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, consequential, whether in contract, in tort, in delict, under statute or otherwise) to any person who is not a client of Stifel in connection with the Review, this announcement, any statement contained herein or otherwise. No representation or warranty, express or implied, is made by Stifel as to the contents of this announcement.



Date   Source Headline
25th Nov 20253:26 pmPRNMonthly Factsheet
25th Nov 202511:42 amPRNApproval of reclassification of Shares
21st Nov 20257:53 amRNSNet Asset Value(s)
20th Nov 20257:41 amRNSNet Asset Value(s)
19th Nov 20257:50 amRNSNet Asset Value(s)
18th Nov 20257:45 amRNSNet Asset Value(s)
17th Nov 20257:53 amRNSNet Asset Value(s)
14th Nov 20257:52 amRNSNet Asset Value(s)
13th Nov 202512:45 pmPRNHolding(s) in Company
13th Nov 20257:49 amRNSNet Asset Value(s)
12th Nov 20257:36 amRNSNet Asset Value(s)
11th Nov 20257:40 amRNSNet Asset Value(s)
10th Nov 202512:18 pmPRNResults of Scheme Elections
10th Nov 20257:22 amRNSNet Asset Value(s)
7th Nov 20258:59 amPRNResult of General Meeting
7th Nov 20257:52 amRNSNet Asset Value(s)
6th Nov 20257:46 amRNSNet Asset Value(s)
5th Nov 20257:38 amRNSNet Asset Value(s)
4th Nov 20257:44 amRNSNet Asset Value(s)
3rd Nov 20254:08 pmPRNTotal Voting Rights
3rd Nov 20257:34 amRNSNet Asset Value(s)
31st Oct 20258:12 amRNSNet Asset Value(s)
30th Oct 20257:37 amRNSNet Asset Value(s)
29th Oct 20257:38 amRNSNet Asset Value(s)
28th Oct 20257:40 amRNSNet Asset Value(s)
27th Oct 20257:57 amRNSNet Asset Value(s)
24th Oct 20257:30 amRNSNet Asset Value(s)
23rd Oct 20259:21 amPRNMonthly Factsheet
23rd Oct 20257:30 amRNSNet Asset Value(s)
22nd Oct 20257:38 amRNSNet Asset Value(s)
21st Oct 20257:42 amRNSNet Asset Value(s)
20th Oct 20257:51 amRNSNet Asset Value(s)
17th Oct 20257:49 amRNSNet Asset Value(s)
16th Oct 20257:47 amRNSNet Asset Value(s)
15th Oct 20257:52 amRNSNet Asset Value(s)
14th Oct 20251:30 pmPRNPublication of Circular and Notice of General Meeting
14th Oct 20257:43 amRNSNet Asset Value(s)
13th Oct 20257:56 amRNSNet Asset Value(s)
10th Oct 20257:53 amRNSNet Asset Value(s)
9th Oct 20257:38 amRNSNet Asset Value(s)
8th Oct 20257:41 amRNSNet Asset Value(s)
7th Oct 20257:42 amRNSNet Asset Value(s)
6th Oct 20257:43 amRNSNet Asset Value(s)
3rd Oct 20257:38 amRNSNet Asset Value(s)
2nd Oct 202511:54 amPRNCancellation of Treasury Shares
2nd Oct 20257:51 amRNSNet Asset Value(s)
1st Oct 20255:30 pmPRNTotal Voting Rights
1st Oct 20257:35 amRNSNet Asset Value(s)
30th Sep 20257:54 amRNSNet Asset Value(s)
29th Sep 20253:58 pmPRNMonthly Factsheet

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.